Incyte (NASDAQ: INCY) awards EVP stock options, 8,999 performance shares
Rhea-AI Filing Summary
Michael James Morrissey, EVP and Head of Technical Operations at Incyte, received two equity awards on July 23, 2026. He was granted 6,426 stock options with a $116.69 exercise price, vesting 25% after one year then monthly over three years, expiring July 22, 2036. He also received 8,999 performance shares, each representing the right to receive up to 200% of one common share based on relative three-year TSR versus a fixed peer group, with earned shares vesting on the third anniversary of the grant, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Morrissey Michael James
Role
EVP, Head of Tech. Operations
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F1 | 6,426 | $0.00 | $0.00 |
| Grant/Award | Performance Shares F2 | 8,999 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 6,426 shares (Direct);
Performance Shares — 8,999 shares (Direct)
Footnotes (2)
- F1. The July 23, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- F2. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
Key Figures
Stock options granted: 6,426 shares
Option exercise price: $116.6900 per share
Option expiration date: July 22, 2036
+3 more
6 metrics
Stock options granted
6,426 shares
Employee Stock Option grant on July 23, 2026
Option exercise price
$116.6900 per share
Exercise price for the 6,426 stock options granted July 23, 2026
Option expiration date
July 22, 2036
Expiration date for the 6,426 stock options
Performance shares granted
8,999 performance shares
Performance Share award on July 23, 2026
Performance period start
January 1, 2026
Beginning of three-year TSR performance period for performance shares
Maximum payout per performance share
up to 200% of one share
Each performance share may deliver up to 200% of one share of common stock
Key Terms
Employee Stock Option (right to buy), Performance Shares, relative total shareholder return ("TSR"), Performance Share Award Agreement
4 terms
Employee Stock Option (right to buy) financial
"Security title reported as Employee Stock Option (right to buy)"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Incyte (INCY) executive Michael James Morrissey receive?
On July 23, 2026, Michael James Morrissey received 6,426 stock options and 8,999 performance shares from Incyte. The options have a fixed exercise price, while the performance shares can deliver up to 200% of one common share each, depending on performance.
What are the key terms of Michael Morrissey’s 6,426 Incyte (INCY) stock options?
Morrissey’s award includes 6,426 stock options with an exercise price of $116.69 per share. The options vest in 37 installments: 25% after one year, then the remainder monthly over three years, and they expire on July 22, 2036.
When do Michael Morrissey’s Incyte (INCY) equity awards vest and expire?
His stock options vest 25% after one year and monthly over the next three years, expiring on July 22, 2036. Earned performance shares vest on the third anniversary of the July 23, 2026 grant date, subject to his continued service with Incyte.